Chakraborty and colleagues [32] recently demonstrated that MICU1 overexpression in ovarian cancer cells induces both glycolysis and chemoresistance and that MICU1 overexpression in patients with ovarian cancer correlates with poor overall survival. Here, MICU1 is linked to ovarian cancer.